Determination of a new biomarker in subjects exposed to 4,4′-methylenediphenyl diisocyanate

References

• Baur X. (1990). New aspects of isocyanate asthma. Lung 168 (Suppl.):606–13.
   PubMedGoogle Scholar
• Baur X, Marek W, Ammon J, Czuppon AB, Marczynski B, Raulf-Heimsoth M, Roemmelt H, and Fruhmann G. (1994). Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health 66:141–52.
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, Milot J, L’Archeveque J, Trudeau C, Lummus Z. (2002). Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Resp Crit Care Med 166:445–50.
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Ott MG, Woolhiser M, Lummus Z, Graham C. (2006). Evaluation of antibody binding to diisocyanate protein conjugates in a general population. Ann Allergy Asthma Immunol 97:357–64.
   PubMed Web of Science ®Google Scholar
• Bernstein JA. (1996). Overview of diisocyanate occupational asthma. Toxicology 111:181–9.
   PubMed Web of Science ®Google Scholar
• Bolognesi C, Baur X, Marczynski B, Norppa H, Sepai O, Sabbioni G. (2001). Carcinogenic risk of toluene diisocyanate and 4,4′-methylenediphenyl diisocyanate: epidemiological and experimental evidence. Crit Rev Toxicol 31:737–72.
   PubMed Web of Science ®Google Scholar
• Delclos KB, Kadlubar FF. (1997). Carcinogenic aromatic amines and amides. In: Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive Toxicology. Oxford, UK: Elsevier Science Ltd. pp. 141–170.
   Google Scholar
• Hoymann HG, Buschmann J, Heinrich U. (1995). Untersuchungen zur chronischen Toxizität/Kanzerogenität von 4,4′-Methylendiphenyl-Diisocyanat (MDI). Forschungsbericht 116 06 084. Hannover, Germany: Fraunhofer-Institut für Toxikologie und Aerosolforschung.
   Google Scholar
• Karol MH. (1986). Respiratory effects of inhaled isocyanates. Crit Rev Toxicol 16:349–79.
   PubMed Web of Science ®Google Scholar
• Kazanis S, McClelland RA. (1992). Electrophilic intermediate in the reaction of glutathione and nitroso arenes. J Am Chem Soc 114:3052–9.
   Web of Science ®Google Scholar
• Krone CA, Klingner TD. (2005). Isocyanates, polyurethane and childhood asthma. Pediatr Allergy Immunol 16:368–79.
   PubMed Web of Science ®Google Scholar
• Kumar A, Dongari N, Sabbioni G. (2009). New isocyanate-specific albumin adducts of 4,4′-methylenediphenyl diisocyanate (MDI) in rats. Chem Res Toxicol 22:1975–83.
   PubMed Web of Science ®Google Scholar
• Liljelind I, Norberg C, Egelrud L, Westberg H, Eriksson K, Nylander-French LA. (2010). Dermal and inhalation exposure to methylene bisphenyl isocyanate (MDI) in iron foundry workers. Ann Occup Hyg 54:31–40.
   PubMed Web of Science ®Google Scholar
• Mapp CE, Saetta M, Maestrelli P, Ciaccia A, Fabbri LM. (1994). Low molecular weight pollutants and asthma: pathogenetic mechanisms and genetic factors. Eur Resp J 7:1559–63.
   PubMed Web of Science ®Google Scholar
• Munn SJ, Allanou R, Aschberger K, Cosgrove O, Pakalin S, Paya-Perez A, Pellegrini G, Schwarz-Schulz B, Vegro S, eds. (2005). EUR 22104 EN European Union Risk Assessment Report: methylenediphenyl diisocyanate (MDI). Vol. 59. Environment and quality of life series. Luxembourg: European Commission, Office for Official Publications of the European Communities.
   Google Scholar
• Ott MG, Jolly AT, Burkert AL, Brown WE. (2007). Issues in diisocyanate antibody testing. Crit Rev Toxicol 37:567–85.
   PubMed Web of Science ®Google Scholar
• Pearson PG, Slatter JG, Rashed MS, Han DH, Baillie TA. (1991). Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcarbamoyl)cysteine, two electrophilic S-linked conjugates of methyl isocyanate. Chem Res Toxicol 4:436–44.
   PubMed Web of Science ®Google Scholar
• Raulf-Heimsoth M, Baur X. (1998). Pathomechanisms and pathophysiology of isocyanate-induced diseases – summary of present knowledge. Am J Ind Med 34:137–43.
   PubMed Web of Science ®Google Scholar
• Redlich CA, Karol MH. (2002). Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2:213–24.
   PubMed Web of Science ®Google Scholar
• Ringe D, Turesky RJ, Skipper PL, Tannenbaum SR. 1988. Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo. Chem Res Toxicol 1:22–4.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Hartley R, Henschler D, Hollrigl-Rosta A, Koeber R, Schneider S. (2000). Isocyanate-specific hemoglobin adduct in rats exposed to 4, 4′-methylenediphenyl diisocyanate. Chem Res Toxicol 13:82–9.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Jones CR. (2002). Biomonitoring of arylamines and nitroarenes. Biomarkers 7:347–421.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Lamb JH, Farmer PB, Sepai O. (1997). Reactions of 4-methylphenyl isocyanate with amino acids. Biomarkers 2:223–32.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Schutze D. (1998). Hemoglobin binding of bicyclic aromatic amines. Chem Res Toxicol 11:471–83.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Wesp H, Lewalter J, Rumler R. (2007). Determination of isocyanate biomarkers in construction site workers. Biomarkers 12:468–83.
   PubMed Web of Science ®Google Scholar
• Schutze D, Sagelsdorff P, Sepai O, Sabbioni G. (1996). Synthesis and quantification of DNA adducts of 4,4′-methylenedianiline. Chem Res Toxicol 9:1103–12.
   PubMed Web of Science ®Google Scholar
• Schutze D, Sepai O, Lewalter J, Miksche L, Henschler D, Sabbioni G. (1995). Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 16:573–82.
   PubMed Web of Science ®Google Scholar
• Sepai O, Schutze D, Heinrich U, Hoymann HG, Henschler D, Sabbioni G. (1995). Hemoglobin adducts and urine metabolites of 4,4′-methylenedianiline after 4,4′-methylenediphenyl diisocyanate exposure of rats. Chem Biol Interact 97:185–98.
   PubMed Web of Science ®Google Scholar
• Skipper PL, Tannenbaum SR. (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11:507–18.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Rashed MS, Pearson PG, Han DH, Baillie TA. (1991). Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chem Res Toxicol 4:157–61.
   PubMed Web of Science ®Google Scholar
• van Kampen V, Merget R, Baur X. (2000). Occupational airway sensitizers: an overview on the respective literature. Am J Ind Med 38:164–218.
   PubMed Web of Science ®Google Scholar
• Vock EH, Hoymann HG, Heinrich U, Lutz WK. (1996). 32P-postlabeling of a DNA adduct derived from 4,4′-methylenedianiline, in the olfactory epithelium of rats exposed by inhalation to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 17:1069–73.
   PubMed Web of Science ®Google Scholar
• Vock EH, Lutz WK. (1997). Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4′-diisocyanate (MDI) in the rat after topical treatment. Toxicol Lett 92:93–100.
   PubMed Web of Science ®Google Scholar
• Wisnewski AV. (2007). Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol 7:138–45.
   PubMedGoogle Scholar
• Wisnewski AV, Liu J, Redlich CA. (2010). Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate. Anal Biochem 400:251–8.
   PubMed Web of Science ®Google Scholar
• Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA. (2000). Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Resp Crit Care Med 162:2330–6.
   PubMed Web of Science ®Google Scholar
• Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA. (2004). Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 113:1178–84.
   PubMed Web of Science ®Google Scholar